6 results
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
21 Apr 22
Additional proxy soliciting materials
4:21pm
savings options and matching contributions. We annually review our workforce demographic and pay equity data to track our performance and inform new
8-K
EX-99.1
696 d85susr7zw07b98
11 Jan 21
Results of Operations and Financial Condition
6:03am
- Prev
- 1
- Next